Thomson Medical GroupFRA:3H5 PB Ratio is 2.92 as of Jul. 11, 2026, which is 13% above its 10-year median of 2.58. The stock has 6 warning signs investors should review. Among 608 Healthcare Providers & Services companies, Thomson Medical Group ranks worse than 67.27% on this metric.
The historical rank and industry rank for Thomson Medical Group's PB Ratio or its related term are showing as below:
FRA:3H5'
s PB Ratio Range Over the Past 10 Years
Min: 0.49 Med: 2.58 Max: 4.84
Current: 3
During the past 13 years, Thomson Medical Group's highest PB Ratio was 4.84. The lowest was 0.49. And the median was 2.58.
FRA:3H5's PB Ratio is ranked worse than 67.27% of 608
companies
in the Healthcare Providers & Services industry
Industry Median: 1.99
vs FRA:3H5: 3.00
During the past 12 months, Thomson Medical Group's average Book Value Per Share Growth Rate was -5.30% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -3.50% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -5.80% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -17.80% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Thomson Medical Group was 55.40% per year. The lowest was -48.00% per year. And the median was -1.30% per year.
Back to Basics: PB Ratio
Thomson Medical Group (FRA:3H5) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Thomson Medical Group's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Thomson Medical Group PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Thomson Medical Group's PB Ratio distribution charts can be found below:
* The bar in red indicates where Thomson Medical Group's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Thomson Medical Group (FRA:3H5) has a PB Ratio of 2.92 as of Jul. 11, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Thomson Medical Group and its competitors. This is 13% above median its historical median of 2.58. Over the past decade, Thomson Medical Group's PB Ratio has ranged from 0.49 to 4.84. According to the industry distribution chart, Thomson Medical Group ranks #409 out of 608 companies in the Healthcare Providers & Services industry, placing it in the top 67.3%.
Is Thomson Medical Group's PB Ratio too high?
Thomson Medical Group's current PB Ratio of 2.92 is 13% above median its 10-year median of 2.58. Over the past 10 years, this metric has ranged from a low of 0.49 to a high of 4.84. The Healthcare Providers & Services industry median PB Ratio is 1.99. Thomson Medical Group's value of 2.92 is 46.7% above this industry median. Based on the distribution chart, Thomson Medical Group ranks #409 out of 608 companies in the Healthcare Providers & Services industry, which is below the industry midpoint.
How does Thomson Medical Group's PB Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Thomson Medical Group ranks #409 out of 608 companies for PB Ratio. This places Thomson Medical Group in the lower half of its industry. The industry median PB Ratio is 1.99. Thomson Medical Group's value of 2.92 is 46.7% above this benchmark. Historically, Thomson Medical Group's own PB Ratio has ranged from 0.49 to 4.84 over the past decade. While the company's 10-year median is 2.58 vs. the industry median of 1.99, Thomson Medical Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 1.99, based on 608 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Thomson Medical Group's current PB Ratio of 2.92 is 46.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Thomson Medical Group and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 1.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Thomson Medical Group's current PB Ratio is 2.92, which is 13% above median its own 10-year median of 2.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Thomson Medical Group stock overvalued right now?
Based on GuruFocus' analysis, Thomson Medical Group (FRA:3H5) is currently considered Possible Value Trap. The stock's GF Value™ is €0.05, compared to a current price of €0.04 — trading 30% below its estimated fair value. The current PB Ratio is 2.92, which is 13% above median its 10-year median of 2.58 and 46.7% above the Healthcare Providers & Services industry median of 1.99. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Thomson Medical Group (FRA:3H5), the current PB Ratio is 2.92 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Thomson Medical Group Ltd is a provider of healthcare services for women and children. Its segments include Hospital services; Specialised services and Investment holdings. It generates maximum revenue from the Specialised services segment. The specialised services segment includes services provided by fertility clinics, paediatric centres, cancer centre, cardiology centre, Chinese medicine, specialist skin centre and a pre-natal and clinical diagnostic laboratory and project-related services such as managing vaccination centres, COVID-19 Treatment Facilities and Transitional Care Facilities. It also includes a consumer business segment, comprising products and services. Geographically, it derives a majority of its revenue from Singapore.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:3H5 has been successfully added to your 